The company focuses on isolation, cryopreservation, and personal storage of stem cells from umbilical cord blood and umbilical cords. Hematopoietic stem cells from umbilical cord blood are used to treat cancer and blood diseases by restoring hematopoiesis and the immune system.
The company operates in 85 Russian cities and has representatives in Kazakhstan and Armenia. It occupies a leading position in the number of samples in storage, about 40% of the Russian market.
Gemabank is a member of the «RUSCORD» and «NASBIO associations».
We provide biobanking, genetic research, and regenerative medicine services for private and corporate clients.
Prevention of blood diseases
Umbilical cord blood contains hematopoietic stem cells (HSCs). They are the source of all hematopoietic and immune system cells, as well as some other types of cells.
If a person’s immune and hematopoietic cells are severely damaged, HSC transplantation can help restore and “reboot” the patient’s entire hematopoietic and immune system.
HSC transplantation is used to treat oncohematological diseases (leukemia), blood diseases (e.g., various types of anemia), and immune system diseases, as well as certain hereditary diseases. In addition, HSCs are being actively implemented in regenerative medicine for the treatment of cerebral palsy, autism, stroke, and many other diseases.
Prevention of blood diseases
After a baby is born and the umbilical cord is cut, umbilical cord tissue can be collected and mesenchymal stem cells (MSCs) can be isolated from it to be stored in the Gemabank cryogenic storage facility along with a piece of the tissue for future use.
The organ MSCs can transform into muscle, nerve, bone, fat, or liver cells.
They are being actively studied by scientists in clinical trials for use in the treatment of regenerative diseases, namely for recovery after injuries, treating heart diseases, liver diseases, arthrosis, ovarian dysfunction syndrome, psoriasis, multiple sclerosis, renal failure, spinal cord pathologies, autism, and many other diseases.
In this case, stem cells are suitable for both the child and his/her relatives.
Neonatal screening
Hemascreen for neonatal genetic screening for the 19 most common curable genetic diseases. An advanced screening option for 375 genetic diseases is also available.
